dichlororibofuranosylbenzimidazole and dinoprostone

dichlororibofuranosylbenzimidazole has been researched along with dinoprostone in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Biskobing, D; Catherwood, BD; Nanes, MS; Rubin, J; Thornton, DL; Titus, L	1

Other Studies

1 other study(ies) available for dichlororibofuranosylbenzimidazole and dinoprostone

Article	Year
1,25(OH)2D3 and cAMP synergistically induce complement 5a receptor messenger RNA. The American journal of the medical sciences, 1996, Volume: 311, Issue:2 Topics: 1-Methyl-3-isobutylxanthine; Antigens, CD; Calcitriol; Cell Line; Complement C5a; Cyclic AMP; Dichlororibofuranosylbenzimidazole; Dinoprostone; DNA-Directed RNA Polymerases; Drug Synergism; Enzyme Inhibitors; Gene Expression Regulation; Receptor, Anaphylatoxin C5a; Receptors, Complement; RNA, Messenger; Time Factors	1996

Article

Year

1,25(OH)2D3 and cAMP synergistically induce complement 5a receptor messenger RNA.

The American journal of the medical sciences, 1996, Volume: 311, Issue:2

Topics: 1-Methyl-3-isobutylxanthine; Antigens, CD; Calcitriol; Cell Line; Complement C5a; Cyclic AMP; Dichlororibofuranosylbenzimidazole; Dinoprostone; DNA-Directed RNA Polymerases; Drug Synergism; Enzyme Inhibitors; Gene Expression Regulation; Receptor, Anaphylatoxin C5a; Receptors, Complement; RNA, Messenger; Time Factors

1996